CARBAMAZEPINE - ANVISA Registration 10345162137

Access comprehensive regulatory information for CARBAMAZEPINE in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10345162137 and manufactured by manufacturer not specified. The registration is held by SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA with validity until May 26, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 4 companies making the same product including MICROGENICS CORPORATION, ABBOTT GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
4 Competitors
10345162137
2 Related Devices
Registration Details
ANVISA Registration Number: 10345162137
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Atellica CH Carbamazepina (Carb)
Risk Class III

Registration Details

10345162137

25351513023201787

01449930000190

Company Information

Dates and Status

Dec 04, 2017

26/05/2035

09/18/2025 19:00:01

Atellica CH Carbamazepina (Carb)
Risk Class III

Registration Details

10345162137

25351513023201787

01449930000190

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Dec 04, 2017

26/05/2035

09/18/2025 19:00:01